Literature DB >> 16462562

Complications associated with the posterolateral approach for pilon fractures.

Timothy Bhattacharyya1, Renn Crichlow, Ruben Gobezie, Edward Kim, Mark S Vrahas.   

Abstract

OBJECTIVE: To review the complication rates of open reduction and internal fixation (ORIF) of tibial pilon fractures using the posterolateral approach.
DESIGN: Retrospective review.
SETTING: Two level I trauma centers. PATIENTS: Nineteen consecutive pilon fractures at an average of 13 (range, 13-45) months follow-up. Average age 46 (range, 21-72) years. Four of 19 were open fractures. INTERVENTION: Because of the high incidence of wound complications associated with the anterior approach for pilon fractures, patients were treated with initial temporary external fixation followed by delayed ORIF through the posterolateral approach to the distal tibia. The hypothesis was that the abundant soft-tissue coverage of the posterior distal tibia would decrease the rate of wound complications. MAIN OUTCOME MEASUREMENTS: The incidence of wound complications, nonunion, and early posttraumatic arthritis. This was a chart and radiograph retrospective review.
RESULTS: The mean time to definitive treatment was 13 (range 2-30) days. Nine of 19 patients (47%) developed complications. There were 6 patients with wound problems, 2 patients with aseptic nonunions, 2 patients with infected nonunions, 3 tibiotalar fusions, and 1 patient with a 3-mm step off. In total, there were 14 major complications in 9 patients. Ten of 19 patients did not have any complication.
CONCLUSIONS: The posterolateral approach does not eliminate the complications common to other approaches, but does offer a potential alternative when soft tissue concerns prevent other approaches. We do not recommend the posterolateral approach for the routine treatment of tibial pilon fractures.

Entities:  

Mesh:

Year:  2006        PMID: 16462562     DOI: 10.1097/01.bot.0000201084.48037.5d

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  8 in total

1.  The direct lateral approach to the distal tibia and fibula: a single incision technique for distal tibial and pilon fractures.

Authors:  John E Femino; Tanawat Vaseenon
Journal:  Iowa Orthop J       Date:  2009

2.  Comparison of Two Surgical Approaches to Supination-External Rotation-Type Ankle Fractures.

Authors:  Bingqian Chen; Zhengfei Wang; Zhi Chen; Xiaohong Qu; Xiaowen Fang; Xuesong Wang; Guoxiu Ke
Journal:  J Healthc Eng       Date:  2022-04-11       Impact factor: 3.822

Review 3.  High-energy pilon fractures management: State of the art.

Authors:  Jordi Tomás-Hernández
Journal:  EFORT Open Rev       Date:  2017-03-13

4.  Surgical approach strategies for open reduction internal fixation of closed complex tibial Pilon fractures based on axial CT scans.

Authors:  Yu Zhao; Jian Wu; Shijun Wei; Feng Xu; Changwang Kong; Xiaosong Zhi; Ming Huang; Xianhua Cai
Journal:  J Orthop Surg Res       Date:  2020-07-27       Impact factor: 2.359

5.  Pilon Fractures: Challenges and Solutions.

Authors:  Bishoy N Saad; John M Yingling; Frank A Liporace; Richard S Yoon
Journal:  Orthop Res Rev       Date:  2019-09-24

6.  Influence of reduction quality on functional outcome and quality of life in treatment of tibial plafond fractures: a retrospective cohort study.

Authors:  Maxim Privalov; Finn Euler; Holger Keil; Benedict Swartman; Nils Beisemann; Jochen Franke; Paul Alfred Grützner; Sven Y Vetter
Journal:  BMC Musculoskelet Disord       Date:  2019-11-13       Impact factor: 2.362

7.  [Modified staging strategy in treatment of type C3 Pilon fractures].

Authors:  Yu Chen; Hui Zhang; Xi Liu; Yaxing Li; Boquan Qin; Yi Ren; Shizhou Wu; Fuguo Huang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-11-15

8.  Additional table for easier access to ankle fracture: A retrospective study of traditional positioning versus modified positioning.

Authors:  Bo Liu; Rui Jin; Saroj Rai; Ruikang Liu; Pan Hong
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.